The reduced bacterial burden observed in mice treated with LPS was associated to a reduced pulmonary inflammation as shown by a lower neutrophil number in BALF and lungs and a decreased mRNA expression of the pro-inflammatory genes Tnfα and Il-6, but not Il-1β and Cxcl1, in lungs (Figures 6E–G). The gene discussed is IL1B; the disease is inflammation.